Interview: Selin Kurnaz, Massive Bio

Selin Kurnaz is Massive Bio’s founder. She holds a PhD in Mechanical Engineering, among half a dozen of other engineering degrees! We sat with her to discuss the use of data for enrollment in oncology clinical trials.

Clinerion: Within the constraints of a tweet (i.e. in max. 280 char.), tell us more about you!

Selin Kurnaz: Before founding my company, Massive Bio, I was working for private equity funds, advising on their investments in healthcare. Back then, I was trying to launch my own growth equity funds. My decision to start Massive Bio was mainly based on my family situation.

My uncle was diagnosed with cancer, and this pushed me, among other personal reasons, to completely change my career; this was a life-changing event.

The interview is published at:

Media Coverage

Leave a Comment

Your email address will not be published.

Previous reading
Our Response to Coronavirus Pandemic and Guidance to Cancer Patients
Next reading
SYNERGY-AI Based Precision Oncology Clinical Trial Matching